These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 32899606)

  • 1. The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease.
    Chernick D; Zhong R; Li L
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances on the antiatherogenic effects of HDL-derived proteins and mimetic peptides.
    Petraki MP; Mantani PT; Tselepis AD
    Curr Pharm Des; 2009; 15(27):3146-66. PubMed ID: 19754388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL and cognition in neurodegenerative disorders.
    Hottman DA; Chernick D; Cheng S; Wang Z; Li L
    Neurobiol Dis; 2014 Dec; 72 Pt A():22-36. PubMed ID: 25131449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease.
    Stukas S; Robert J; Wellington CL
    Cell Metab; 2014 Apr; 19(4):574-91. PubMed ID: 24508505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL and Therapy.
    Li K; Xie X; Guo Y
    Adv Exp Med Biol; 2022; 1377():171-187. PubMed ID: 35575930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoprotective Functions of High-Density Lipoproteins Relevant to Alzheimer's Disease Are Partially Conserved in Apolipoprotein B-Depleted Plasma.
    Button EB; Gilmour M; Cheema HK; Martin EM; Agbay A; Robert J; Wellington CL
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders.
    Getz GS; Wool GD; Reardon CA
    Curr Pharm Des; 2010; 16(28):3173-84. PubMed ID: 20687877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
    Robert J; Stukas S; Button E; Cheng WH; Lee M; Fan J; Wilkinson A; Kulic I; Wright SD; Wellington CL
    Biochim Biophys Acta; 2016 May; 1862(5):1027-36. PubMed ID: 26454209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL from an Alzheimer's disease perspective.
    Button EB; Robert J; Caffrey TM; Fan J; Zhao W; Wellington CL
    Curr Opin Lipidol; 2019 Jun; 30(3):224-234. PubMed ID: 30946049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?
    Koudinov AR; Berezov TT; Koudinova NV
    Neurosci Lett; 2001 Nov; 314(3):115-8. PubMed ID: 11704297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences.
    Francis GA
    Biochim Biophys Acta; 2000 Jan; 1483(2):217-35. PubMed ID: 10634938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant high-density lipoproteins and their use in cardiovascular diseases.
    Cao YN; Xu L; Han YC; Wang YN; Liu G; Qi R
    Drug Discov Today; 2017 Jan; 22(1):180-185. PubMed ID: 27591840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics.
    Jin Y; Chifodya K; Han G; Jiang W; Chen Y; Shi Y; Xu Q; Xi Y; Wang J; Zhou J; Zhang H; Ding Y
    J Control Release; 2021 Oct; 338():56-70. PubMed ID: 34391838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.
    Kon V; Yang H; Fazio S
    Arch Med Res; 2015 Jul; 46(5):379-91. PubMed ID: 26009251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?
    Mulder M; Terwel D
    Haemostasis; 1998; 28(3-4):174-94. PubMed ID: 10420065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein mimetics in cancer.
    Delk SC; Chattopadhyay A; Escola-Gil JC; Fogelman AM; Reddy ST
    Semin Cancer Biol; 2021 Aug; 73():158-168. PubMed ID: 33188891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease.
    Martins IJ; Berger T; Sharman MJ; Verdile G; Fuller SJ; Martins RN
    J Neurochem; 2009 Dec; 111(6):1275-308. PubMed ID: 20050287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL-Targeted Therapies During Myocardial Infarction.
    Sposito AC; Carmo HR; Barreto J; Sun L; Carvalho LSF; Feinstein SB; Zanotti I; Kontush A; Remaley A
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):371-381. PubMed ID: 30778806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders.
    Turri M; Marchi C; Adorni MP; Calabresi L; Zimetti F
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 May; 1867(5):159123. PubMed ID: 35151900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia.
    Chernick D; Ortiz-Valle S; Jeong A; Swaminathan SK; Kandimalla KK; Rebeck GW; Li L
    J Neurochem; 2018 Dec; 147(5):647-662. PubMed ID: 30028014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.